Showing results (51-60 of 217) with videos related to

Sort By:
Pageof 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Using the expected survival to explain differences between the results of randomized trials: a case in advanced ovarian cancerMarc Buyse, Tomasz Burzykowski, Mahesh Parmar, et al.
Future Oncology (London, England)|September 1, 2025
Interstitial lung disease epidemiology and etiology in patients with solid malignant tumors: a systematic literature reviewEgbert F Smit, Simon M Collin, Manoj Prahladan, et al.
The International Journal of Biological Markers|June 15, 2010
Predictive and prognostic role of p53 according to tumor phenotype in breast cancer patients treated with preoperative chemotherapy: a single-institution analysisValentina Guarneri, Elena Barbieri, Federico Piacentini, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 16, 2013
Body mass index and prognosis of metastatic breast cancer patients receiving first-line chemotherapyAlessandra Gennari, Oriana Nanni, Matteo Puntoni, et al.
Anticancer Research|April 12, 2015
Epirubicin plus paclitaxel regimen as second-line treatment of patients with small-cell lung cancerGiulia Pasello, Paolo Carli, Fabio Canova, et al.
British Journal of Cancer|March 10, 2022
Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg?Laura Bonanno, Alessandro Dal Maso, Alberto Pavan, et al.
Nuclear Medicine Communications|April 15, 2017
Diagnostic and prognostic impact of fluorine-18-fluorodeoxyglucose PET/CT in preoperative and postoperative setting of breast cancer patientsLaura Evangelista, Anna R Cervino, Silvia Michieletto, et al.
NPJ Breast Cancer|February 4, 2023
Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trialMaria Vittoria Dieci, Giancarlo Bisagni, Stefania Bartolini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 31, 2015
Could semiquantitative FDG analysis add information to the prognosis in patients with stage II/III breast cancer undergoing neoadjuvant treatment?Laura Evangelista, Anna Rita Cervino, Cristina Ghiotto, et al.
Annals of Surgical Oncology|January 10, 2015
Preoperative carboplatin-paclitaxel-bevacizumab in triple-negative breast cancer: final results of the phase II Ca.Pa.Be studyValentina Guarneri, Maria Vittoria Dieci, Giancarlo Bisagni, et al.
Pageof 22